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ABSTRACT
The majority of transcripts that harbor an internal
ribosome entry site (IRES) are involved in cancer de-
velopment via corresponding proteins. A crucial
event in tumor progression referred to as epithelial
to mesenchymal transition (EMT) allows carcinoma
cells to acquire invasive properties. The translation-
al activation of the extracellular matrix component
laminin B1 (LamB1) during EMT has been recently
reported suggesting an IRES-mediated mechanism.
In this study, the IRES activity of LamB1 was deter-
mined by independent bicistronic reporter assays.
Strong evidences exclude an impact of cryptic
promoter or splice sites on IRES-driven translation
of LamB1. Furthermore, no other LamB1 mRNA
species arising from alternative transcription start
sites or polyadenylation signals were detected that
account for its translational control. Mapping of the
LamB1 50-untranslated region (UTR) revealed the
minimal LamB1 IRES motif between  293 and  1
upstream of the start codon. Notably, RNA affinity
purification showed that the La protein interacts
with the LamB1 IRES. This interaction and its regu-
lation during EMT were confirmed by ribonucleo-
protein immunoprecipitation. In addition, La was
able to positively modulate LamB1 IRES translation.
In summary, these data indicate that the LamB1
IRES is activated by binding to La which leads to
translational upregulation during hepatocellular EMT.
INTRODUCTION
The interaction of tumor cells with the extracellular matrix
(ECM) is essential for cancer invasion and metastasis.
Laminins constitute the ECM as the main non-
collagenous glycoproteins of the basement membrane and
affect the migratory behavior of a variety of malignant cell
types (1). Laminin B1 (LamB1) represents one moiety of
the three b-subunits that assemble with a- and g-chains to
form a multitude of heterotrimeric laminin isoforms (2).
LamB1 modulates laminin-mediated integrin signaling
that promotes cell adhesion, motility and differentiation
(3). In addition, LamB1 is the ligand of the monomeric
67-kDa laminin receptor [LamR; (4–6)] that drives tumor
cell invasion as well as angiogenesis and is strongly ex-
pressed in many metastatic cancers (7–9). The over-
expression of LamB1 has been particularly reported in
hepatocellular carcinoma (HCC), which is frequently pre-
ceded by ﬁbrosis and cirrhosis and thus accompanied by
increased ECM deposition. Accordingly, LamB1 expres-
sion is augmented during transforming growth factor
(TGF)-b induced liver ﬁbrosis of transgenic mice (10).
Proteome analysis of HCC patients revealed a rise of
LamB1 levels in cirrhotic tissue and a further increase in
carcinoma cells (11). The elevated LamB1 expression in
HCC associates with upregulation of b1 integrin and
LamR (12–14).
A crucial event in tumor progression is the gain of
invasive properties of carcinoma cells by epithelial to mes-
enchymal transition (EMT). This process is character-
ized by the loss of epithelial cell polarity and acquisition
of a ﬁbroblastoid phenotype enabling tumor cells to leave
epithelial cell organization (15). In HCC cells, EMT
can be induced by the synergy of TGF-b and oncogenic
Ras signaling, which are frequently activated in HCC
patients (15–18). Recently, we showed that LamB1
is translationally upregulated in HCC cells that have
undergone EMT through the cooperation of TGF-b
with Ras (19). The translational activation of LamB1
was proposed to be regulated by an internal ribosome
entry site (IRES).
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50-untranslated region (UTR) of the mRNA allows direct
ribosome binding and translation initiation independently
of the cap structure. Translation of key regulatory
proteins that are involved in cancer-relevant processes
such as angiogenesis, mitosis and apoptosis is frequently
driven by internal initiation (20). IRES-translated tran-
scripts escape from downregulation of cap-dependent
protein synthesis and foster tumor cells to overcome stress
conditions induced by hypoxia or nutrient deprivation
(21). Deregulation of translation control affects IRES-
mediated translation in a dual way. Cap-dependent trans-
lation of IRES-competent transcripts is increased in the
presence of high levels of activated translation initiation
factor eIF4E, while same transcripts are translated by
IRES-dependent mechanism when eIF4E is downregul-
ated in response to cellular stress or other stimuli
(22,23). Furthermore, IRES-mediated translation is regu-
lated by IRES transacting factors (ITAFs) which mainly
comprise heterogeneous nuclear ribonucleoproteins
(hnRNPs) that shuttle between cytoplasm and nucleus
(24). ITAFs selectively bind IRES structures and modulate
their activity, allowing a distinguished response of IRES
transcripts to cellular conditions that affect translation. A
role of ITAFs in regulating cell survival and angiogenesis
has been described although little is known about
tumor-associated alterations of ITAFs (25).
Here we demonstrate that the 50-UTR of LamB1
harbors a bona ﬁde IRES structure localized between
 293 and  1 upstream of the start codon. RNA afﬁnity
puriﬁcation as well as in vivo UV crosslinking combined
with RNP immunoprecipitation allowed the identiﬁcation
of La protein as an ITAF that binds to the LamB1 IRES.
Moreover, La was found to positively regulate the LamB1
IRES activity which might account for the increased IRES
mediated LamB1 translation of EMT-transformed
hepatocytes.
MATERIAL AND METHODS
Construction of the plasmids
The LamB1 50-UTR was cloned downstream of the Fireﬂy
luciferase open reading frame (ORF) into p-F resulting in
pLam-F(19). Primers were designed according to
GenBank sequence NM_002291. Plasmids for the cryptic
promoter assay were generated by removal of the CMV
promoter from pF, pLam-F and pEMCV-F (19).
Bicistronic plasmids were constructed based on the
pbgal/50(-162)/CAT vector (a kind gift from Dr Martin
Holcik) (26). The XIAP IRES sequence was removed
from pbgal/50(-162)/CAT to generate the empty control
vector pbgal/CAT, or replaced by the LamB1 50-UTR re-
sulting in pbgal/Lam/CAT. Deletion fragments for the
mapping of the 50-UTR were ampliﬁed by PCR and
cloned into pbgal/CAT. Primer sequences are shown in
Supplementary Table S1. Plasmids for the streptavidin-
tethered RNA afﬁnity puriﬁcation were generated by in-
serting the LamB1 50-UTR or the minimal XIAP IRES
sequence into the pTrap vector (kindly provided by
Dr Martin Dienstbier) (27). Primer sequences are shown
in Supplementary Table S2.
Cell culture
Immortalized murine MIM-1-4 hepatocytes were grown
on collagen-coated culture dishes in RPMI 1640 plus
10% fetal calf serum (FCS), 40ng/ml human TGF-a
(Sigma, St. Louis, USA), 30ng/ml human insulin-like
growth factor II (IGF-II, Sigma, St. Louis, USA),
1.4nM insulin (Sigma, St. Louis, USA) and antibiotics,
as described previously (28). Malignant epithelial
MIM-R hepatocytes are derived from MIM-1-4 cells by
expressing oncogenic Ha-Ras and green ﬂuorescent pro-
tein as outlined recently (29). TGF-b1 (R&D Systems,
Minneapolis, USA) was used at a concentration of
2.5ng/ml for the ﬁrst 72h of EMT induction. For
long-term treatment of MIM-R hepatocytes, TGF-b1
was supplemented to the medium at a concentration of
1ng/ml, resulting in ﬁbroblastoid MIM-RT cells after
>2 weeks. Human SW480 and HEK293 cells were
cultured in DMEM and HepG2 cells in MNP each plus
10% FCS. The human HCC cell lines Hep3B and AKH3p
were grown in RPMI 1640 medium supplemented with
10% FCS. All cells were kept at 37 C and 5% CO2 and
routinely screened for the absence of mycoplasma.
Western blot analysis
The preparation of cellular extracts, separation of proteins
by SDS–PAGE and immunoblotting were performed as
described recently (18). Cytoplasmic and nuclear cell frac-
tions were generated using a Proteo-JET kit (Fermentas,
St.Leon-Rot, Germany) according to the manufacturers’
description. A total of 30mg protein extract was loaded
onto gels and immunological detection of proteins was
performed with the Super Signal detection system (Pierce
Chemical Company, Rockford, USA). The following
primary antibodies were used: anti-laminin B1 (Neo
Markers, Fremont, USA), 1:1000; anti-hnRNP A1
(Santa Cruz Biotechnology, California, USA), 1:1000;
anti-actin (Sigma, St. Louis, USA), 1:2000; anti-La
(Santa Cruz Biotechnology, California, USA) and (Cell
Signaling, MA, USA), 1:1000; anti-tubulin (Sigma, St.
Louis, USA), 1:1000; anti-nucleoporin (BD Biosciences,
NJ, USA), 1:1000. Secondary antibodies (Calbiochem,
LaJolla, USA) were used at dilutions of 1:10000.
Reverse transcriptase (RT)–polymerase chain reaction
(PCR), quantitative (q)PCR and RACE–PCR
RNA was extracted, DNaseI treated and reverse
transcribed using a RNA isolation and cDNA synthesis
kit (Quiagen, Hilden, Germany) as recommended by the
manufacturer. Aliquotes of the cDNA were employed
for Reverse transcriptase-polymerase chain reaction
(RT–PCR) using Ready-To-Go PCR beads (Amersham,
Uppsala, Sweden). Ampliﬁcation products of semi-
quantitative PCR were visualized by ethidium bromide
staining on a 1% agarose gel. Primer sequences are
shown in Supplementary Table S3. qPCR was performed
with Fast SYBR green (Applied Biosystems, CA, USA)
according to the recommendations of the manufacturer
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(Applied Biosystems). Primer sequences are shown in
Supplementary Table S4. 50- and 30-RACE–PCR was per-
formed using a First Choice RLM–RACE Kit (Applied
Biosystems, CA, USA) according to the manufacturer’s
recommendation. Primer sequences are shown in
Supplementary Table S5.
Transient transfection and reporter assays
Cells were plated on six-well plates and transiently trans-
fected after 24h with Lipofectamine Plus as recommended
by the manufacturer (Invitrogen, Carlsbad, USA). Cells
were lysed 48h post-transfection and enzymatic re-
porter activities were determined. Luciferase activity was
measured with a Luminoskan microplate reader
(Labsystems, Farnborough, UK) as recently described
(19). b-galactosidase (b-gal) activity was photometrically
determined using o-nitrophenyl-b-D-galactopyranoside
and chloramphenicol acetyltransferase (CAT) activity
was measured by ELISA (Roche, Mannheim, Germany)
as recommended by the manufacturer. In assays analyzing
the interference of cap-dependent translation, reporter
activities were normalized to mRNA levels as quantiﬁed
by qPCR. Otherwise, relative IRES activity of bicistronic
assays was calculated as the ratio of CAT/b-gal.
Luciferase activities of monocistonic vectors were normal-
ized to b-gal activities of a co-transfected b-gal reporter
(19). Assays were performed in triplicate and results rep-
resent the average of three independent experiments.
RNA–protein immunoprecipitation
Cells were transfected with a bicistronic vector as described
above or directly UV crosslinked with 400mJ/cm
2 before
cell lysis. Lysates were centrifuged at 1200g and super-
natants were aliquoted corresponding to 3 10
6 cells.
An amount of 5mg La antibody (Santa Cruz
Biotechnology, California, USA) were crosslinked to
50ml Dynabeads Protein A (Invitogen, California,
USA) using Bis(sulfosuccinimidyl)suberate (BS
3; Thermo
Fisher Scientiﬁc, Massachusetts, USA) as described by the
manufacturer. Crosslinked Dynabeads were incubated
with aliquots of pre-cleared cell lysates at room tempera-
ture, washed and the immunoprecipitated RNA–protein
complexes were eluted at 95 C. Eluates were treated with
proteinase K (Fermentas, St. Leon-Rot, Germany) and
the RNA was ethanol-precipitated after extraction with
phenol–chloroform. After treatment with DNaseI
(Fermentas), mRNA was puriﬁed using a mRNA isola-
tion kit (Roche, Mannheim, Germany) and subjected to
cDNA synthesis. Subsequent RT–PCR or qPCR was per-
formed as described above. To determine the amount of
input RNA that was used for immunoprecipitation, RNA
was isolated from aliquots of cell lysates using a RNA
isolation kit (Quiagen, Hilden, Germany), treated with
proteinase K and processed as described above. The
buffer for cell lysis and immunoprecipitation consisted
of 30mM HEPES pH 7.3, 160mM KCl, 2.5mM MgCl2,
1mM DTT, 0.1% NP-40, 0.5% Triton X-100 and 10%
glycerol. The washing buffer included PBS pH 7.4 and
0.02% Tween. The elution buffer was composed of
100mM Tris–HCl pH 7.4, 5% SDS, 70mM
b-mercaptoethanol and 5mM DTT.
Northern blot analysis
Cells were grown on a 6-cm culture dish and transfected
with bicistronic vectors using Lipofectamine Plus as rec-
ommended by the manufacturer (Invitrogen, Carlsbad,
USA). mRNA was isolated with a mRNA isolation kit
(Roche, Mannheim, Germany). RNA samples were heated
at 65 C for 15min in RNA sample buffer, cooled on ice
and separated on a MOPS–formaldehyde agarose gel.
RNA was transferred to a membrane (NEN life science
products, MA, USA) and UV crosslinked. Probes were
ampliﬁed by PCR from the pbgal/Lam/CAT vector in
the presence of
32P-labeled dCTP. Primer sequences are
described in Supplementary Table S6. Unincorporated
nucleotides were removed using a Gel extraction Kit
(Quiagen, Hilden, Germany). Membranes were
pre-hybridized for 4h and then hybridized over night at
42 C with 5 10
7cpm of radiolabeled probe. Membranes
were washed at 65 C and exposed to x-ray ﬁlms at  80 C.
In vitro translation
Bicistronic vectors containing the LamB1 50-UTR or
XIAP IRES were in vitro transcribed using a
MEGAshortscript kit (Applied Biosystems, CA, USA).
Rabbit reticulocyte lysate (RRL) (Promega, Madison,
USA) was programmed with the transcripts and in vitro
translation was performed according to the guidelines of
the manufacturer. CAT activities were determined by
ELISA (Roche, Mannheim, Germany) and normalized
to transcript levels quantiﬁed by CAT RT–PCR. In
order to pre-clear the reticulocyte lysate from La, 5mg
La antibody was crosslinked to 50ml Dynabeads
Protein A (Invitogen, California, USA) by using BS
3 as
described by the manufacturer (Thermo Fisher Scientiﬁc,
Massachusetts, USA). Reticulocyte lysate was incubated
with crosslinked Dynabeads for 30min at room tempera-
ture followed by removal of Dynabeads. An amount of
1mg of recombinant La (Prospec, Rehovot, Israel) was
added to reconstitute La activity. Results show the
average of three independent experiments.
Streptavidin-tethered RNA afﬁnity puriﬁcation
A total of 2 10
7 cells were lysed and pre-cleared with
50ml streptavidin-linked magnetic beads (Sigma, St.
Louis, USA). Another 50ml of magnetic beads were
washed and resuspended in 200ml buffer. An amount of
5mgo fin vitro transcribed S1-aptamer fused RNA and
5ml RNasin (Promega, Madison, USA) were added and
the beads were incubated on a thermomixer for 90min at
4 C with moderate shaking. RNA-associated beads were
washed with 200ml buffer and further incubated with the
pre-cleared protein extract on a thermomixer for 90min at
4 C while shaking. Beads were then washed ﬁve times with
buffer. RNA–protein complexes were eluted by incubating
with buffer containing biotin at a ﬁnal concentration of
10mM at 4 C for 160min. Eluted proteins were analyzed
by SDS–PAGE followed by silver staining or western blot.
The buffer used for cell lysis, afﬁnity chromatography,
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160mM KCl, 2.5mM MgCl2, 1mM DTT, 0.1% NP-40,
0.5% Triton X-100 and 10% glycerol.
Stable knock-down of La
MISSION shRNA lentiviral transduction particles
(Sigma, St. Louis, USA) were used to knock-down La
(NM_009278) in MIM-R and MIM-RT hepatocytes.
Cells were transduced with viral particles containing
shRNA against La (TRCN0000071284, TRCN00
00071287) or non-target shRNA (SHC002V) in a
pLKO.1 vector and treated with puromycine (5mg/ml)
for selection.
Statistical analysis
Data were expressed as means SD. The statistical signiﬁ-
cance of differences was evaluated using a paired, non-
parametric Student’s t-test. Signiﬁcant differences between
experimental groups were *P<0.05, **P<0.01 or
***P<0.005.
RESULTS
LamB1 mRNA in cancer cells
Recently we identiﬁed the cap-independent translational
upregulation of LamB1 during TGF-b-induced EMT of
epithelial MIM-R hepatocytes to invasive, ﬁbroblastoid
MIM-RT cells (19). To further assess translational
control of LamB1 during EMT, we studied a conceivable
impact of LamB1 mRNA isoforms. Differential utilization
of transcripts generated by e.g. alternative splicing is
known to cause aberrant gene expression during oncogen-
esis (30). Notably, the LamB1 50-UTR sequence published
in NCBI (NM_002291.2) is not entirely supported by ex-
pressed sequence tags (ESTs) or full length cDNA.
Rather, the EST database dbEST contains transcripts
that start at  147nt or further downstream and fail to
conﬁrm the region from  335 to  154 in the 50-UTR.
In silico analysis of the 50-UTR using Zuckers mfold
version 4.11 predicted a strong secondary structure with
a minimal free energy of  154kcal/mol which could
account for insufﬁcient ampliﬁcation and could explain
missing ESTs (31,32). Therefore, we tested whether the
ﬁrst 1–181nt of the published sequence were ampliﬁed
from DNA contaminations. Interestingly, RT–PCR
analysis of different human cell lines after DNase treat-
ment showed ampliﬁcation of the entire 50-UTR sequence
comprising 335nt as published in NCBI (Figure 1A).
Combined DNase and RNase treatment failed to show
amplicons, excluding the presence of DNA. Thus, our
data conﬁrm the expression of the published human
LamB1 50-UTR sequence.
Furthermore, we performed RACE–PCR of the 50- and
30-UTR to identify any transcript variants that may be in-
volved in translational regulation of LamB1 (Figure 1B).
In accordance, we were able to amplify a single 335-nt
long 50-UTR sequence in various human cancer cell
lines. No other transcripts were detected suggesting the
absence of alternative splice products of the LamB1
50-UTR. In addition, we analyzed variations in the
LamB1 30-UTR since shortening of the 30-UTR by alter-
native cleavage or polyadenylation was demonstrated to
be involved in translational activation of oncogenes (33).
RACE–PCR of the 30-UTR resulted in a single amp-
licon of 135nt, indicating that the LamB1 30-UTR is
not altered in tumorigenesis. Consistently, LamB1
northern blot analysis of two human tumor cell lines dis-
played single transcripts (Figure 1C). Together, these
data suggest that translation of LamB1 is not regulated
by alternative 50-UTR species or shortening of the
30-UTR.
Figure 1. LamB1 UTRs in cancer cells. (A) The entire LamB1 50-UTR containing 335nt was ampliﬁed from various human cancer cells. Non-treated
(nt), DNase- (D) or DNase plus RNase-treated (D/R) mRNA populations were subjected to RT–PCR (M, marker). (B) RACE–PCR of the LamB1
50- and 30-UTR in human cancer cell lines resulted in single amplicons of expected size. (C) Northern blot analysis revealed a single LamB1
transcript.
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EMT-transformed cells
We recently showed that the LamB1 50-UTR directs trans-
lation of a bicistronic transcript when inserted in the
intercistronic region of a vector containing Renilla and
Fireﬂy luciferase reporters (19). Although this bicistronic
vector is widely used there have been issues with false
positive signals derived by alternative splicing (34,35).
Furthermore, it has been described that intensities of
IRES activities can strongly vary depending on the type
of bicistronic reporters (36,37). Therefore we employed an
alternative bicistronic vector encoding b-galactosidase
(b-gal) as upstream and CAT as downstream reporter
(34). The LamB1 50-UTR was inserted into the inter-
cistronic region and the empty vector served as negative
control (Figure 2A). Since the cellular IRES of X linked
inhibitor of apoptosis (XIAP) and its ITAFs are well
documented, the minimal XIAP IRES sequence was
utilized as positive control (26,38,39). Human SW480
colon carcinoma cells were transfected with bicistronic
vectors and b-gal and CAT activities were determined
(Figure 2B). Reporter activities were normalized to
mRNA levels quantiﬁed by qPCR, and thus display the
ratio of active protein to bicistronic transcript levels allow-
ing conclusions on translation efﬁciencies. These data
show an about 7-fold increase of LamB1 IRES-mediated
CAT translation as compared to control. Figure 2C nor-
malizes CAT to cap-dependent b-gal translation rates of
the bicistronic transcripts, indicating a >6-fold upre-
gulation of LamB1 IRES activity. These data corroborate
our recent ﬁndings and demonstrate that the LamB1
50-UTR mediates cap-independent translation in two in-
dependent bicistronic reporter systems (19).
We next analyzed whether the IRES activity of LamB1
is regulated upon hepatocellular EMT by employing
bicistronic experiments in immortalized MIM-1-4 hepato-
cytes, malignant epithelial MIM-R hepatocytes that were
transformed with oncogenic Ras as well as in those that
have undergone EMT upon TGF-b treatment (MIM-RT).
All cells were transfected with bicistronic constructs con-
taining either the LamB1 50-UTR, the minimal XIAP
IRES or the empty vector. b-gal (Figure 2D) or CAT
activities (Figure 2E) were normalized to transcript levels
and displayed as the ratio of IRES- to cap-dependent
translation (Figure 2F). As expected, b-gal levels displayed
no signiﬁcant variations of cap-dependent translation
rates in the cell lines (Figure 2D). CAT activities were
Figure 2. The LamB1 50-UTR shows IRES activity that is activated during EMT. (A) Vectors employed for the bicistronic assay contain the full
length LamB1 50-UTR or the minimal XIAP IRES within the linker region of the b-gal and CAT reporter. The empty vector is taken as negative
control. (B) SW480 colon carcinoma cells were transfected with bicistronic vector and b-gal and CAT activities were determined after 48h. b-gal and
CAT activities were normalized to transcript levels as quantiﬁed by qPCR. (C) The LamB1 50-UTR as well as the XIAP display IRES activity in
human SW480 cells. Shown is the ratio of IRES-mediated CAT to cap-dependent b-gal translation. (D) b-gal and (E) CAT activities of MIM-1-4,
MIM-R and MIM-RT cells each transfected with bicistronic vectors. Cells were lysed after 48h and reporter activities were normalized to mRNA
levels as quantiﬁed by qPCR. (F) As depicted by the ratio of CAT to b-gal activity, MIM-RT cells that have undergone EMT by TGF-b show
signiﬁcant upregulation of LamB1 IRES activity as compared to Ras-transformed malignant MIM-R hepatocytes. *P<0.05, **P<0.01 or
***P<0.005.
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cytes as compared to epithelial MIM-R cells (Figure 2E),
suggesting activation of LamB1 IRES translation upon
hepatocellular EMT. Normalization of b-gal to CAT
activities as shown in Figure 2F revealed comparable
data as depicted in Figure 2E. These results are consistent
with recently published data that were obtained using
Renilla and Fireﬂy luciferase reporters (19). Notably,
LamB1 IRES translation showed higher levels than
XIAP in the malignant progression of hepatocytes
(Figure 2E and F). This effect might be cell type speciﬁc
since LamB1 and XIAP exhibited similar activities in
SW480 colon cancer cells (Figure 2C). Together, these
data show that the LamB1 50-UTR confers translation of
the downstream cistron in the b-gal/CAT constructs, indi-
cating IRES-mediated translation. Furthermore, LamB1-
driven IRES translation in this assay is activated upon
hepatocellular EMT which corroborates recent data (19).
The LamB1 50-UTR does not direct aberrant transcription
or cryptic splicing
Bicistronic assays to determine IRES activity have been
criticized since reporter activity of the downstream cistron
may arise from the presence of cryptic promoter or splice
sites within the 50-UTR rather than from the IRES.
In order to detect any aberrant bicistronic transcripts,
we performed northern blot analysis of SW480 and
MIM-R cells transfected with the bicistronic vector con-
taining LamB1 50-UTR or empty control. Probes for
the b-gal and CAT reporter hybridized to the bicistronic
mRNA revealed single transcripts of equal size
(Figure 3A). Truncated mRNAs generated from cryptic
promoter or splice sites could not be detected. As
northern blot analysis could fail to detect smaller tran-
scripts due to limited sensitivity, we determined the ratio
of CAT to b-gal cistrons by qPCR. This analysis revealed
that ratios were comparable between bicistronic vectors
containing either XIAP IRES, LamB1 50-UTR or empty
control (Figure 3B). These data indicate that the LamB1
50-UTR does not direct aberrant transcription or splicing.
To further analyze cryptic promoter activity, we con-
structed vectors containing the LamB1 50-UTR, the
EMCV IRES or the empty control upstream of a Fireﬂy
luciferase reporter, each in presence or absence of a CMV
promoter. These vectors were transfected into MIM-R
hepatocytes together with a b-gal reporter plasmid
and Fireﬂy activities were normalized to b-gal levels
(Figure 3C). Interestingly, promoterless plasmids showed
residual luciferase activities of 6–8%. However, these re-
maining activities are considered to be independent of the
Figure 3. LamB1 IRES activity is not affected by cryptic promoter or splice sites. (A) Northern blot analysis of murine MIM-R hepatocytes and
human SW480 colon cancer cells transfected with bicistronic constructs. Hybridization with probes for the b-gal and CAT reporter revealed single
transcripts of equal size. Arrows indicate the position of 28S and 18S rRNA on the blot. 28S rRNA is shown as a loading control. (B) qPCR for
b-gal and CAT in cells transfected with bicistronic vectors were normalized to RhoA levels, resulting in equal CAT to b-gal ratios for the vector
containing LamB1 50-UTR and empty control. (C) To test cryptic promoter activity in the LamB1 50-UTR, the sequence was cloned upstream of a
Fireﬂy luciferase reporter and the CMV promoter was removed. The viral EMCV IRES and the empty vector were used as negative controls. Vectors
were co-transfected with a b-gal expressing plasmid into MIM-R cells. Fireﬂy luciferase activities were measured after 48h and normalized to b-gal
activities. (D) The cryptic promoter activity of the Fireﬂy reporter was analyzed by linear semiquantitative RT–PCR using primer localized within the
LamB1 50-UTR (A–C) or the Fireﬂy luciferase ORF (D–F). Arrows mark the position of forward primer each giving rise to an amplicon with 400–
500nt. Samples were treated with RNase to detect DNA contaminations.
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were almost equally detected in vectors under investiga-
tion. These results suggest that cryptic transcription
occurs within the Fireﬂy luciferase, which has already
been reported (40). To identify the origin of the aberrant
transcription, we performed RT–PCR using primer that
bind within the LamB1 50-UTR (A–C) or within the
Fireﬂy luciferase ORF (D–F; Figure 3D). To exclude
DNA contaminations RNA extracts were treated with
RNase resulting in no amplicon. Only primer located
within the Fireﬂy luciferase (E,F) ampliﬁed transcripts
of promoterless vectors in presence or absence of the
LamB1 50-UTR, suggesting a cryptic promoter activity
within the Fireﬂy luciferase rather than in the LamB1
50-UTR. These data provide strong evidence that the
LamB1 50-UTR does not drive aberrant transcription
and that translation of the bicistronic vector containing
the LamB1 50-UTR was indeed mediated by an IRES.
Determination of the minimal LamB1 IRES motif
To determine the minimal cis-acting IRES motif of the
LamB1 50-UTR, we generated bicistronic constructs con-
taining deleted fragments of the 50-UTR (Figure 4). The
sequence was truncated in steps of 50nt starting from the
50-o r3 0-end. MIM-R and MIM-RT hepatocytes were
transfected with the constructs and CAT activities were
normalized to b-gal levels. The segment between  293
ans  1 upstream of the start codon retained full IRES
activity, while the region between  241 and  1 showed
reduced IRES activity indicating that the minimal IRES
motif starts within  293 and  241. A sequence upstream
of the start codon containing 82nt ( 82 to  1) displayed
31% activity of the full length 50-UTR and therefore might
have still some ability to attract the translation initiation
complex. Deletion of this region caused a reduced activity
of the remaining fragment ( 335 to  82) to 64% of the
full length 50-UTR, suggesting that it is not essential for
internal ribosome binding but may work as an enhancer of
IRES activity. Furthermore, a motif that regulates IRES
activity in response to TGF-b induced EMT might start
within  241 to  180, since the  241 to  1 fragment is
still regulated between MIM-R and MIM-RT cells while
50-deletion to  180nt results in similar IRES activities in
both cell lines. Taken together these data reveal a minimal
IRES motif required for translational activity that starts
between  293 and  241 and ends between  82 and  1,
and in addition, suggest an IRES domain between  241
and  180 that responds to TGF-b.
La interacts with the LamB1 50-UTR in vitro and in vivo
IRES-driven translation has been shown to be regulated
by ITAFs (24). Therefore, we aimed to identify RNA-
binding proteins that interact with the LamB1 50-UTR
by streptavidin-tethered RNA afﬁnity puriﬁcation.
Constructs containing the LamB1 50-UTR or the minimal
XIAP IRES downstream of two S1 aptamers were
generated. The minimal XIAP IRES was applied as
control for selectivity since several interacting ITAFs
have already been described (38,39,41). The constructs
were in vitro transcribed and RNA was conjugated to
magnetic streptavidin beads. Whole protein extracts of
HEK293 cells were incubated with either streptavidin
beads alone, streptavidin beads conjugated to the tran-
script of the LamB1 50-UTR or streptavidin beads
conjugated to the XIAP transcript. Elution with biotin
allowed a high selectivity for RNA associated proteins.
Analysis by SDS electrophoresis followed by silver staining
revealed a 47-kDa protein that interacts with the LamB1
50-UTR (Figure 5A). This protein was identiﬁed as La/
SSB by western blot analysis (Figure 5B). The La
protein as well as the 37-kDa protein hnRNP A1 bound
to the XIAP control RNA. Both ITAFs have been
described as regulators of XIAP IRES activity and there-
fore demonstrate the selectivity of this experimental
approach (38,39). The control reaction using streptavidin
beads alone did not yield any proteins (Figure 5A and B).
From these data we concluded that La selectively binds
the LamB1 50-UTR in vitro.
This interaction was veriﬁed in vivo by anti-La RNA
immunoprecipitation (IP) (Figure 5C). Lysates were gene-
rated from SW480 or HEK293 cells after UV crosslinking
of RNA–protein complexes. Cell lysates were immunopre-
cipitated with magnetic beads conjugated to La antibody
or unconjugated beads as control. RNA was isolated from
either cell lysates (Input), IP with anti-La conjugated
beads (La) or unconjugated beads (beads) and RT–PCR
was performed. To exclude the presence of DNA contam-
inations, a control reaction without reverse transcription
(r.t.) was included. The ability of the antibody to precipi-
tate the La protein was veriﬁed by western blot
(Supplementary Figure S1). As shown in Figure 5C,
LamB1 and XIAP but not Actin transcripts could be
ampliﬁed from the immunoprecipitated mRNA in both
cell lines. While XIAP serves as a positive control, actin
mRNA is known to lack interaction with La, showing the
Figure 4. Cis-acting sequence requirements for LamB1 IRES activity.
The sequence of the LamB1 50-UTR was deleted in steps of approxi-
mately 50nt starting from the 50-UTR or 30-UTR and cloned into the
bicistronic b-gal/CAT reporter vector. IRES activities of bicistronic
vectors were determined after transfection into MIM-R and MIM-RT
cells. Lysates were analyzed after 48h post-transfection and CAT
activities were normalized to b-gal activities.
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physical interaction of La with the LamB1 mRNA in
two different human cell lines. To further investigate this
interaction and analyze whether La binds the LamB1
50-UTR in vivo, the La-IP was performed in HEK293
cells transfected with the bicistronic construct containing
either the LamB1 50-UTR, the XIAP IRES or the empty
control. RT–PCR for the CAT reporter revealed that La
selectively binds the LamB1 50-UTR and XIAP IRES but
not the empty vector (Figure 5D). Taken together, these
data show that La associates with the LamB1 50-UTR
in vitro and in vivo.
La binding to the LamB1 IRES is regulated upon EMT
Since La represents an ITAF that binds to the LamB1
50-UTR, we next investigated whether the interaction
between La and the LamB1 IRES is regulated during
EMT. Therefore we performed La RNA-IP employing
epithelial MIM-R and ﬁbroblastoid MIM-RT hepato-
cytes. Cells were transfected with bicistronic vectors con-
taining the minimal LamB1 IRES, the XIAP IRES or the
empty control. RT–PCR for the CAT reporter revealed
that La binds to the LamB1 and XIAP IRES in MIM-R
as well as MIM-RT cells (Figure 6A). qPCR for the CAT
reporter was performed to reliably quantify the amount of
LamB1 bicistronic transcripts that interact with La in each
cell line (Figure 6B). Quantiﬁed levels of immunopre-
cipitated bicistronic transcripts were normalized to the
amount of bicistronic transcript that was used for the
IP. Interestingly, higher levels of La protein associated
with the minimal LamB1 IRES in MIM-RT cells than in
MIM-R cells suggesting that the interaction of La with the
LamB1 50-UTR is upregulated after EMT. This obser-
vation is consistent with the bicistronic assay that
revealed a signiﬁcant increase of IRES activity upon
EMT (Figure 2F) and with recent data showing that La
is an activator of several cellular IRESs (39,43,44). We
further investigated the regulation of La during EMT in
our cell model. Western blot analysis revealed comparable
levels of La protein in MIM-R and MIM-RT cells, while
LamB1 expression was clearly elevated in EMT-
transformed cells (Figure 6C). Thus, La is not regulated
during EMT at the level of total protein expression. As
recent reports described that La can shuttle between
nucleus and cytoplasm, we studied this possible mode of
regulation by subcellular fractionation. Interestingly,
western blot analysis showed that MIM-RT cells display
increased cytoplasmic La levels compared to MIM-R cells
(Figure 6D). In addition, treatment of MIM-R cells with
TGF-b resulted in slightly enhanced cytoplasmic levels of
La protein. Notably, elevated levels of cytoplasmic La
correlated with LamB1 upregulation. In summary, these
data suggest that La protein accumulates in the cytoplasm
during TGF-b induced EMT, where it binds to the min-
imal LamB1 IRES motif to increase translation.
LamB1 IRES activity is enhanced by La
As the interaction of La with the LamB1 IRES is
regulated upon EMT, we investigated whether La
enhances IRES-mediated translation of LamB1.
Figure 5. Identiﬁcation of La interacting with the LamB1 IRES. (A) The LamB1 50-UTR or XIAP minimal IRES were cloned into the pTrap vector.
In vitro transcription of the linearized vector resulted in transcripts containing two S1 aptamers that bind streptavidin followed by the sequence of
interest. The transcripts were linked to streptavidin beads and employed to pull down proteins from HEK293 cell extract. RNA–protein complexes
were subjected to SDS electrophoresis. Silver staining shows a 47-kDa protein interacting with both the LamB1 and XIAP IRES and a 37-kDa
protein interacting with the XIAP IRES only. (B) Proteins were identiﬁed by western blotting as La (47kDa) and hnRNPA1 (37kDa). (C) Lysates of
UV crosslinked SW480 and HEK293 cells were subjected to RNA-IP using the La antibody followed by RT–PCR for LamB1. cDNA was generated
with or without reverse transcriptase (r.t.) to detect DNA contaminations. (D) HEK293 cells were transfected with bicistronic vectors, UV
crosslinked after 48h and subjected to RNA-IP employing the La antibody followed by RT–PCR for CAT.
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activity using an in vitro translation assay (Figure 7A).
Rabbit reticulocyte lysate (RRL) was programmed with
in vitro transcribed bicistronic RNA containing the
LamB1 50-UTR and the IRES-dependent CAT activities
were determined. Prior to in vitro translation, RRL was
pre-cleared from La with magnetic beads conjugated to La
antibody or incubated with unconjugated beads as
control. The pre-clearing of lysates was veriﬁed by
western blot analysis (Supplementary Figure S2).
Treatment with unconjungated beads resulted in a slight
decrease of CAT activity suggesting that some factors
required for LamB1 IRES translation unspeciﬁcally bind
to the beads. When RRL was pre-cleared from La, the
CAT activity was further signiﬁcantly decreased (Figure
7A). Notably, the reduced LamB1 50-UTR mediated
translation could be restored by addition of recombinant
La. These results suggest that La positively affects
IRES-driven translation of LamB1. Since La has been
described as activator of XIAP IRES translation, we
employed the minimal XIAP IRES in the same experimen-
tal setting, which led to similar results [Supplementary
Figure S3; (39)]. These data suggest that La works
as an ITAF that binds to the minimal LamB1 IRES
and enhances its translational activity during
hepatocellular EMT.
To study the effect of La on LamB1 IRES translation
in vivo, we generated MIM-R and MIM-RT cells with a
Figure 6. The binding of La to the LamB1 IRES is regulated upon EMT. (A) MIM-R and MIM-RT cells were transfected with bicistronic vectors
containing the minimal LamB1 IRES, the minimal XIAP IRES or the empty control and after 48h UV crosslinked prior to cell lysis. Cell extracts
were immunoprecipitated with La antibody followed by RT–PCR for the CAT reporter. cDNA was generated with or without reverse transcriptase
(r.t.) to detect DNA contaminations. (B) Levels of La bound to LamB1 bicistronic transcripts were quantiﬁed by qPCR and normalized to LamB1
RNA input levels. (C) Total protein levels of La and LamB1 in MIM1-4, MIM-Ras and MIM-RT cells were analyzed by western blotting.
(D) Nuclear and cytoplasmic fractions of MIM-R and MIM-RT cells as well as MIM-R hepatocytes treated for 24h with 2.5ng/ml TGF-b
analyzed by western blotting. The purity of cytoplasmic and nuclear cell fractions was assessed by tubulin and nucleoporin, respectively.
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analysis revealed a strong knock-down of La using two
different shRNA constructs (shLa 84, shLa 87) as
compared to non-target control (sh-NT) or untreated
cells (ctrl) (Figure 7B). Notably, MIM-RT but not
MIM-R cells showed reduced levels of LamB1 after
knock-down of La. These data suggest that La mediated
stimulation of IRES-driven LamB1 translation after EMT
is diminished by silencing of La. To further study the
effect of impaired La expression on LamB1 IRES
activity, bicistronic assays were performed (Figure 7C).
MIM-R and MIM-RT cells with a stable knock-down of
La (shLa 84, shLa 87), non-target shRNA (sh-NT) or the
untreated control (ctrl) were transfected with a bicistronic
vector containing the LamB1 50-UTR. Remarkably,
LamB1 IRES activity was signiﬁcantly reduced in EMT-
transformed MIM-RT cells harboring a La knock-down.
In contrast, the knock-down of La had no signiﬁcant
effect on LamB1 IRES activity in MIM-R cells. These
data concurs with the regulation of LamB1 protein expres-
sion (Figure 7B), indicating that La enhances
IRES-mediated translation during EMT, which is
impaired after knock-down of La.
DISCUSSION
LamB1 is the b-subunit of laminin isoforms that consti-
tute the ECM and contribute to tumor invasion and me-
tastasis. The control of LamB1 expression at the
transcriptional level by retinoic acid is well described,
while the regulation at the level of translation is poorly
understood (45). We recently provided ﬁrst evidence for
IRES-mediated translation of the LamB1 50-UTR by
using bicistronic Renilla-Fireﬂy luciferase assays (19).
However, it has been reported that the level of IRES
activity can strongly vary depending on the type of
bicistronic reporters (36,37). In addition, suspicious
splicing has been detected with a Renilla-Fireﬂy luciferase
vector (34,35). To verify our recent results, we therefore
utilized an alternative bicistronic system encoding b-gal as
upstream and CAT as downstream reporter (34).
Consistently, the LamB1 50-UTR was able to mediate
cap-independent translation of the downstream cistron
in murine and human cell lines (Figure 2). Interestingly,
the bicistronic activity of LamB1 and minimal XIAP
IRES was similar in human SW480 colon cancer cells
while it was strongly increased in murine MIM hepato-
cytes. These data indicate that the LamB1 IRES activity
depends on the cellular context rather than on the
bicistronic vector used for the determination of IRES
activity.
Since bicistronic activity of the downstream reporter
may result from cryptic promoter or splice sites within
the 50-UTR, we performed various assays to reliably
exclude aberrant transcripts. Northern blot analysis as
well as qPCR for b-gal and CAT reporters did not reveal
any truncated bicistronic mRNAs (Figure 3). Noteworthy,
the accurate determination of cryptic promoter activity by
employing a monocistronic Fireﬂy luciferase vector re-
sulted in residual reporter activities after removal of the
CMV promoter (Figure 3C). These enzymatic activities
were detected independently of the presence of the
LamB1 50-UTR. RT–PCR revealed short transcripts
generated by the Fireﬂy luciferase reporter of the pro-
moterless vector indicating a cryptic activity of the
reporter itself as already described [Figure 3D, (40)].
Figure 7. La stimulates IRES-driven LamB1 translation. (A) Rabbit reticulocyte lysate (RRL) was programmed with the bicistronic vector con-
taining the LamB1 50-UTR. Lysates were pre-cleared (precl.) with beads crosslinked to La antibody (+) or with non-conjugated beads (beads).
Depletion of La from lysates reduced LamB1 IRES-mediated translation of the CAT reporter and addition of 1mg recombinant La restored LamB1
IRES activity. *P<0.05. (B) MIM-R and MIM-RT cells were lentivirally infected with two different shRNA contructs against La (shLa 84, shLa 87)
or non-target shRNA (sh-NT). The knock-down of La compared to the untreated control (ctrl) as detected by western blotting. (C) The generated
cell lines were transfected with a bicistronic vector containing the LamB1 50-UTR. Lysates were analyzed 48h post-transfection and CAT activities
were normalized to b-gal activities. *P<0.05 or **P<0.01.
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roborate a bona ﬁde IRES activity of the LamB1 50-UTR
(19), which requires a minimal cis-acting IRES motif
localized between  293 and  1nt upstream of the start
codon (Figure 4)
IRES-mediated de novo synthesis of proteins involved in
angiogenesis, apoptosis or mitosis plays an important role
during tumorigenesis. We initially found by expression
proﬁling that LamB1 is translationally upregulated in
Ras-transformed hepatocytes (MIM-R) that undergo
EMT in response to TGF-b (MIM-RT) (19). In this
study, the bicistronic assay showed a 2.7-fold increase of
IRES activity in EMT-transformed cells suggesting that
elevated LamB1 levels result from activated IRES trans-
lation (Figure 2E). However, diverse mechanisms are
known to account for selective translational control in
cancer cells including alternative splicing of the 50-o r
30-UTR shortening through alternative cleavage or
polyadenylation (30,33). To test a possible involvement
of transcript species in the regulation of LamB1 expression
during tumorigenesis, we performed RACE–PCR of
the 50- and 30-UTR. No alternative transcript variants
could be detected in different human carcinoma cell lines
(Figure 1B). These results are consistent with northern
blot analysis suggesting that LamB1 translation is not
regulated by alternative splicing or 30-UTR shortening
(Figure 1C). Therefore, the elevated translation of
LamB1 upon EMT is caused by IRES activation and
does not involve alternative splicing or 30-UTR
shortening.
Hence, we next aimed to identify ITAFs that interact
with the LamB1 IRES and activate its translation upon
EMT. Streptavidin-tethered RNA afﬁnity puriﬁcation
with a transcript containing the LamB1 50-UTR down-
stream of two S1 aptamers revealed that La selectively
binds the 50-UTR in vitro (Figure 5A). This ﬁnding was
veriﬁed in vivo by an anti-La RNA-IP of UV crosslinked
cells in two human cell lines (Figure 5C). Consistent with
our data, a recently published RNA-IP of BCR/
ABL-transformed myeloid cells revealed LamB1 mRNA
associated to La but not to hnRNP A1, hnRNP E2 or
hnRNP K (42). Furthermore, La binds the LamB1
50-UTR as well as the minimal LamB1 IRES within the
bicistronic transcript after transient transfection of cells
(Figures 5D and 6A). The amount of La that is associated
with the minimal IRES is signiﬁcantly elevated in
EMT-transformed MIM-RT cells as compared to
MIM-R hepatocytes (Figure 6B). Accordingly, western
blot analysis of cytoplasmic and nuclear cell fractions
revealed the cytoplasmic translocation of La in response
to TGF-b induced EMT (Figure 6D). Furthermore, La
enhanced LamB1 IRES activity in an in vitro translation
assay (Figure 7A), suggesting that the elevated levels of
LamB1 in EMT-transformed cells results from increased
IRES-mediated translation in the presence of cytoplasmic
La. In line with these data, the stable knock-down of La
signiﬁcantly reduced LamB1 IRES activity of a bicistronic
construct in EMT-transformed cells (Figure 7C). In
addition, endogenous LamB1 protein levels were
decreased in La-silenced mesenchymal cells (Figure 7B).
In contrast, La knock-down in epithelial cells did not
affect LamB1 IRES translation and endogenous LamB1
protein levels. In summary, these results suggest that La
accumulates in the cytoplasm during hepatocellular EMT,
where it binds the minimal LamB1 IRES motif to enhance
IRES-mediated translation.
A role of La in the LamB1 regulation during EMT is of
particular interest as recent studies suggest an important
role of La in carcinogenesis. La is a RNA-binding protein
involved in RNA processing and translation that predom-
inantly localizes in the nucleus (46). Elevated La levels
have been reported in chronic myeloid leukemia cells,
cervical cancer and several types of cancer cell lines
(19,47,48). La was shown to activate IRES-dependent
translation of XIAP which supports tumorigenesis by pre-
venting apoptosis (39). In addition, La regulates the
IRES-mediated expression of cyclin D1 that stimulates
cell proliferation (19). Accordingly, we found cyclin D1
translationally upregulated in MIM-RT hepatocytes that
have undergone EMT by employing polysome-bound
versus total RNA (data not shown). Furthermore,
AKT-dependent shuttling of La to the cytoplasm leads
to translational activation of a speciﬁc mRNA subset in
glial cells suggesting that La could be involved in onco-
genic effects of aberrant AKT activation in cancer cells
(49). In this respect, it will be of relevance to dissect the
molecular mechanisms of La activated LamB1 IRES
translation in the context of EMT that is induced by the
synergy of Ras and TGF-b signaling and involves the ac-
tivation of AKT and MAPK pathways (18).
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